.jpg)
.png)
Body:
The NLA today released its position on the use Icosapent Ethyl in High and Very-high-risk patients.
Category:
Front Page
Meeting Coverage
Dates:
Friday, September 13, 2019 to Friday, December 6, 2019
Link the Feature to::
This page was last updated: Nov 20, 2019